Stay updated on Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial
Sign up to get notified when there's something new on the Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial page.

Latest updates to the Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2 and removed the prior funding-status notice and the Revision: v3.4.1 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a site-wide notice regarding a lapse in government funding and updated system revision to v3.4.1 (from v3.4.0).SummaryDifference0.3%

- Check28 days agoChange DetectedGlossary toggle added and color-coded diff indicators introduced. The revision tag updated to v3.4.0, and the No FEAR Act label was updated (added as 'No FEAR Act Data' and the older 'No FEAR Act data' label removed).SummaryDifference0.4%

- Check42 days agoChange DetectedThe page history now shows a new revision: v3.3.4, and the previous revision v3.3.3 has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedFooter changes: added 'Revision: v3.3.3'; removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check85 days agoChange DetectedVersion 3.3.2 on 2025-11-26 adds Contacts/Locations and updates Study Status for NCT04916470.SummaryDifference0.3%

Stay in the know with updates to Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial page.